Keywords: aventis, lantus, launched, usa, long-acting, basal, insulin
Aventis' Lantus launched in USA
Article | 24 May 2001
Aventis' long-acting basal insulin Lantus (insulin glargine) for thecontrol of hyperglycemia related to type 1 or type 2 diabetes is now prescribable ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
